Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

Neuroscience

Volumn 178, Issue , 2011, Pages 159-168

  Chen, X ^a   Zhang, J ^a   Chen, C ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Endocannabinoids; Monoacylglycerol lipase; Neurodegeneration; Neuroinflammation

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ACYLGLYCEROL LIPASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; CAPSAICIN; CYCLOOXYGENASE 2; ENDOCANNABINOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; RIMONABANT; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; HIPPOCAMPUS; HYDROLYSIS; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; ARACHIDONIC ACIDS; BENZODIOXOLES; BIPHENYL COMPOUNDS; BORNANES; CAPSAICIN; CELL CULTURE TECHNIQUES; DRUG INTERACTIONS; ENDOCANNABINOIDS; GLYCERIDES; HIPPOCAMPUS; MONOACYLGLYCEROL LIPASES; NERVE DEGENERATION; PEPTIDE FRAGMENTS; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 79952004102     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.01.024     Document Type: Article

References (46)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 2002, 68:247-286.
2. Bisogno T., Di Marzo V. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses. Curr Pharm Des 2008, 14:2299-3305.
3. Blankman J.L., Simon G.M., Cravavtt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonylglycerol. Chem Biol 2007, 14:1347-1356.
4. Cabral G.A., Marciano-Cabral F. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol 2005, 78:1192-1197.
5. Carrier E.J., Kearn C.S., Barkmeier A.J., Breese N.M., Yang W., Nithipatikom K., Pfister S.L., Campbell W.B., Hillard C.J. Cultured rat microglial cells synthesize the endocannabinoids 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol Pharmacol 2004, 65:999-1007.
6. Centonze D., Finazzi-Agro A., Bernardi G., Maccarrone M. The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 2007, 28:180-187.
7. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76.
8. Comelli F., Giagnoni G., Bettoni I., Colleoni M., Costa B. The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation. Br J Pharmacol 2007, 152:787-794.
9. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.I., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 2002, 99:10819-10824.
10. Eljaschewitsch E., et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006, 49:67-79.
11. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
12. Gao Y., et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 2010, 30(6):2017-2024.
13. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., Uhl G.R. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006, 1071:10-23.
14. Gopez J.J., et al. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 2005, 56:590-604.
15. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
16. King A.R., et al. URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol 2007, 14:1357-1365.
17. Koppel J., Davies P. Targeting the endocannabinoid system in Alzheimer's disease. J Alzheimers Dis 2008, 15:495-504.
18. Kozak K.R., Prusakiewicz J.L., Marnett L.J. Oxidative metabolism of endocannabinoids by COX-2. Curr Pharm Des 2004, 10:659-667.
19. Long J.Z., Normura D.K., Cravatt B.F. Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem Biol 2009, 16:744-753.
20. Long J.Z., et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009, 5:37-44.
21. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006, 46:101-122.
22. Marchalanta Y., Brothersa H.M., Wenka G.L. Inflammation and aging: can endocannabinoids help?. Biomed Pharmacother 2008, 62:212-217.
23. Marrs W.R., et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 2010, 13:951-957.
24. Marsicano G., Moosmann B., Hermann H., Lutz B., Behl C. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 2002, 80. 448-428.
25. Marsicano G., et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 2003, 302:84-88.
26. Melis M., et al. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis 2006, 24:15-27.
27. Milton N.G.N. Anandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide. Neurosci Lett 2002, 332:127-130.
28. Pan B., Wang W., Long J.Z., Sun D., Hillard C.J., Cravatt B.F., Liu Q.S. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther 2009, 331(2):591-597.
29. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R., Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001, 413:427-531.
30. Panikashvili D., Mechoulam R., Beni S.M., Alexandrovich A., Shohami E. CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. J Cereb Blood Flow Metab 2005, 25:477-484.
31. Panikashvili D., Shein N.A., Mechoulam R., Trembovler V., Kohen R., Alexandrovich A., Shohami E. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006, 22:257-264.
32. Pertwee R.G. Cannabinoid receptors and pain. Prog Neurobiol 2001, 63:569-611.
33. Piomelli D. The molecular logic of endocannabinoid signaling. Nat Rev Neurosci 2003, 4:873-884.
34. Ramírez B.G., Blazquez C., del Pulgar T.G., Guzman M., de Ceballos M.L. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection medicated by blockade of microglial activation. J Neurosci 2005, 25:1904-1913.
35. Sang N., Zhang J., Marcheselli V., Bazan N.G., Chen C. Postsynaptically synthesized prostaglandin E2 modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor. J Neurosci 2005, 25:9858-9870.
36. Sang N., Chen C. Lipid signaling and synaptic plasticity. Neuroscientist 2006, 12:425-434.
37. Sang N., Zhang J., Chen C. COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J Neurochem 2007, 103:1966-1977.
38. Sang N., Zhang J., Chen C. Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. Neurochem Int 2010, 56:590-596.
39. Sarne Y., Mechoulam R. Cannabinoids: between neuroprotection and neurotoxicity. Curr Drug Targets CNS Neurol Disord 2005, 4:677-684.
40. Stella N., Schweitzer P., Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997, 388:773-778.
41. Sugiura T., Kishimoto S., Oka S., Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 2006, 45:405-446.
42. Van der Stelt M., Di Marzo V. Cannabinoid receptors and their role in neuroprotection. Neuromol Med 2005, 7:37-50.
43. Van der Stelt M., et al. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 2006, 63:1410-1424.
44. Van Sickle M.D., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
45. Walter L., Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol 2004, 141:775-785.
46. Zhang J., Chen C. Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. J Biol Chem 2008, 283:22601-22611.